In August CTS begins source plasma testing as a new line of business to one of the largest plasma fractionators in the industry.
In October, due to demand from existing healthcare partners, CTS began testing blood donors for anti...
CTS Tampa lab implemented the Ortho Clinical Diagnostics VITROS® testing platform to perform COVID-1...
In July, the six viral marker assay conversion at CTS Dallas, Phoenix and Tampa laboratories was ach...
In 2016, CTS tested more source plasma samples (4.9 million) than blood donor samples (4.5 million).
In April, CTS becomes the first blood donor testing organization in the US to implement Zika testing...
By the end of 2017, CTS has secured three source plasma partners and continues to seek additional pa...